AstraZeneca COVID-19 vaccine not linked to blood clot risk, EU drug agency says

Far riskier to not get the shot

Europe’s medical regulator said Thursday the AstraZeneca vaccine is “safe and effective” and not associated with a higher blood clot risk after more than a dozen countries paused rollouts over health fears. The European Medicines Agency says it’s far riskier to not get the shot as several countries face a worrying rise in coronavirus cases.

“The committee has come to a clear scientific conclusion: this is a safe and effective vaccine,” European Medicines Agency chief Emer Cooke said Thursday after a probe by the body’s safety committee.  

This comes as the U.S. has agreed to free up 1.5 million doses of its AstraZeneca supply and send it to Canada.

Barrie Mayor Jeff Lehman says this is great news with more Pfizer and other vaccines en route to Canada, “The good news about getting AstraZeneca is it’s more flexible, and the health unit has been able to deliver that in different ways. And we start to get into true mass vaccination campaigns when it’s not just one or two clinics, trying to push people through, which is what we’ve been doing with Pfizer since Christmas, but now multiple vaccines in multiple different settings.”

Barring production issues, Canada is on track to have one covid vaccine dose for every Canadian by July 1.

Simcoe-Muskoka expecting over 29,000 COVID-19 vaccine doses during the week of March 22

Several schools in Peel Region have been closed due to COVID outbreaks, and teachers at other schools in the region have been told to wear face shields or goggles.

And with a third wave of COVID confirmed in Ontario there is concern younger adults will be hit harder. Some regions are seeing those aged 40 to 75 being hit hard by the Variants of Concern in some regions with
younger patients arriving at hospitals in more serious condition than patients in previous waves.

banner image via Flickr